TransMedics (TMDX) Other Operating Expenses (2023)
TransMedics' (TMDX) quarterly Other Operating Expenses came in at $27.2 million in Q3 2023.
TransMedics (TMDX) Other Operating Expenses (2023) Analysis & Trends
TransMedics' Other Operating Expenses history runs 1 years deep, the most recent figure standing at $27.2 million for Q3 2023.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $27.2 million in Q3 2023; TTM through Jun 2024 was $27.2 million, a N/A change from a year earlier, with the FY2023 full-year figure at $27.2 million, changed N/A from the prior year.
- Other Operating Expenses steadied at $27.2 million in Q3 2023 per TMDX's latest filing.
- Across five years, Other Operating Expenses topped out at $27.2 million in Q3 2023 and bottomed at $27.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 27.21 Mn |